The brainstem tau cytoskeletal pathology of Alzheimer’s disease: A brief historical overview and description of its anatomical distribution pattern, evolutional features, pathogenetic and clinical relevance

Current Alzheimer Research

Volumn 13, Issue 10, 2016, Pages 1178-1197

  RÜb, Udo ^a   Stratmann, Katharina ^a   Heinsen, Helmut ^b,c   Del Turco, Domenico ^a   Seidel, Kay ^a   den Dunnen, Wilfred ^d   Korf, Horst Werner ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Alzheimer s disease; Brainstem; Cytoskeletal pathology; Pathoanatomy; Tau

Indexed keywords

CYTOSKELETON PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANATOMICAL CONCEPTS; ATTENTION DISTURBANCE; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM; BRAIN CORTEX; BRAIN STEM; CELL LOSS; CENTRAL AND PERIAQUEDUCTAL GRAY; CYTOSKELETON; DEPRESSION; DORSAL COCHLEAR NUCLEUS; DORSAL MOTOR VAGAL AND SOLITARY NUCLEUS; EDINGER WESTPHAL NUCLEUS; EVOLUTION; EYE MOVEMENT DISORDER; GENETICS; GIGANTOCELLULAR RETICULAR NUCLEUS; HALLUCINATION; HUMAN; IMMUNOHISTOCHEMISTRY; INFERIOR COLLICULUS; INTERMEDIATE RETICULAR ZONE; LOCUS CERULEUS; MEDULLA OBLONGATA; MESENCEPHALON; MYDRIASIS; NERVE CELL; NEUROPATHOLOGY; PARABRACHIAL NUCLEUS; PATHOGENETIC; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PERIAQUEDUCTAL GRAY MATTER; PONS; PRIORITY JOURNAL; RAPHE NUCLEUS; RETICULOTEGMENTAL NUCLEUS OF PONS; REVIEW; ROSTRAL INTERSTITIAL NUCLEUS OF THE MEDIAL LONGITUDINAL FASCICULUS; SACCADIC EYE MOVEMENT; SILVER STAINING; SLEEP PATTERN; SLEEP WAKING CYCLE; SUBSTANTIA NIGRA; SUPERIOR OLIVARY NUCLEUS; COMPLICATION; METABOLISM; PATHOLOGY; SLEEP WAKE DISORDERS;

ALZHEIMER DISEASE; BRAIN STEM; CYTOSKELETON; HUMANS; SLEEP WAKE DISORDERS; TAU PROTEINS;

EID: 84986907061     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205013666160606100509     Document Type: Review

References (85)

1. Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet 368: 387-403 (2006).
2. Jellinger KA. Alzheimer 100--highlights in the history of Alzheimer research. J Neural Transm 113: 1603-23 (2006).
3. Jalbert JJ, Daiello LA, Lapane KL. Dementia of the Alzheimer type. Epidemiol Rev 30: 15-34 (2008).
4. Braak H, Del Trecidi K. Neuroanatomy and pathology of sporadic Alzheimer's disease. Adv Anat Embryol Cell Biol 215: 1-162 (2015).
5. Stratmann K, Heinsen H, Korf HW, Del Turco D, Seidel, K, Bouzrou M et al. Precortical phases of Alzheimer’s disease (AD)-related tau cytoskeletal pathology. Brain Pathol 26: 371-86 (2016).
6. Lace GL, Wharton SB, Ince PG. A brief history of tau: the evolving view of the microtubule-associated protein tau in neurodegenerative diseases. Clin Neuropathol 26: 43-58 (2007).
7. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet 377: 1019-31 (2011).
8. Saper CB, Wainer BH, German DC. Axonal and transneuronal transport in the transmission of neurological disease: potential role in system degenerations, including Alzheimer's disease. Neuroscience 23: 389-98 (1987).
9. Kalia M. Dysphagia and aspiration pneumonia in patients with Alzheimer's disease. Metabolism 52: 36-8 (2003).
10. German DC, White CL, III, Sparkman DR. Alzheimer's disease: neurofibrillary tangles in nuclei that project to the cerebral cortex. Neuroscience 21: 305-12 (1987).
11. Braak H, Braak E. Neuropathological stageing of Alzheimerrelated changes. Acta Neuropathol 8: 239-59 (1991).
12. Duyckaerts C, Hauw JJ. Diagnosis and staging of Alzheimer disease. Neurobiol Aging 18: S33-S42 (1997).
13. Terwel D, Dewachter I, Van LF. Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease. Neuromol Med 2: 151-65 (2002).
14. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112: 389-404 (2006).
15. Goedert M, Klug A, Crowther RA. Tau protein, the paired helical filament and Alzheimer's disease. J Alzheimers Dis 9: 195-207 (2006).
16. Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H et al. Staging of neurofibrillary pathology in Alzheimer's dis ease: a study of the BrainNet Europe Consortium. Brain Pathol 18: 484-96 (2008).
17. Alonso AC, Li B, Grundke-Iqbal I, Iqbal K. Mechanism of tauinduced neurodegeneration in Alzheimer disease and related tauopathies. Curr Alzheimer Res 5: 375-84 (2008).
18. Iqbal K, Grundke-Iqbal I. Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention. J Cell Mol Med 12: 38-55 (2008).
19. Duyckaerts C, Delatour B, Potier MC. Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118: 5-36 (2009).
20. Iqbal K, Liu F, Gong CX, Alonso AC, Grundke-Iqbal I. Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 118: 53-69 (2009).
21. Iqbal K, Liu F, Gong CX, Grundke-Iqbal I. Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res 7: 656-64 (2010).
22. Walker LC, Diamond MI, Duff KE, Hyman BT. Mechanisms of protein seeding in neurodegenerative diseases. Arch Neurol 70: 304-10 (2013).
23. Braak E, Braak H, Mandelkow EM. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87: 554-67 (1994).
24. Grinberg LT, Rub U, Ferretti RE, Nitrini R, Farfel JM, Polichiso L, et al. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset? Neuropathol Appl Neurobiol 35: 406-16 (2009).
25. Rub U, Del Tredici K, Schultz C, Thal DR, Braak E, Braak H. The evolution of Alzheimer's disease-related cytoskeletal pathology in the human raphe nuclei. Neuropathol Appl Neurobiol 26: 553-67 (2000).
26. Goedert M, Clavaguera F, Tolnay M. The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 33: 317-25 (2010).
27. Jucker M, Walker LC. Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 70: 532-40 (2011).
28. Duyckaerts C, Hauw JJ. Prevalence, incidence and duration of Braak's stages in the general population: can we know? Neurobiol Aging 18: 362-9 (1997).
29. Braak H. Uber die Kerngebiete des menschlichen Hirnstammes. II. Die Raphekerne. Z Zellforsch 107: 123-41 (1970).
30. Olszewski J, Baxter D. Cytoarchitecture of the human brain stem, 2nd ed. Basel: Karger (1982).
31. Saper CB, Petito CK. Correspondence of melanin-pigmented neurons in human brain with A1-A14 catecholamine cell groups. Brain 105: 87-101 (1982).
32. Ohm TG, Braak H. The pigmented subpeduncular nucleus: a neuromelanin-containing nucleus in the human pontine tegmentum. Morphology and changes in Alzheimer's disease. Acta Neuropathol 77: 26-32 (1988).
33. Martin GF, Holstege G, amd Mehler WR. Reticular formation of the pons and medulla. In (Ed: Paxinos G). The human central nervous system. San Diego: Academic Press pp. 203-220 (1990).
34. Paxinos G, Tork I, Halliday G, Mehler WR. Human homologs to brainstem nuclei identified in other animals as revealed by acetylcholinesterase activity. In (Ed: Paxinos G). The human central nervous system. San Diego: Academic Press pp. 149-202 (1990).
35. Pearson J, Halliday G, Sakamoto N, Michel JP. Catecholaminergic neurons. In (Ed: Paxinos G). The human central nervous system. San Diego: Academic Press pp. 1023-1049 (1990).
36. Saper CB. Cholinergic system. In: Paxinos G, Ed. The human central nervous system. San Diego: Academic Press pp. 1095-1113 (1990).
37. Tork I, Hornung JP. Raphe nuclei and the serotoninergic system. In: Paxinos G, Ed. The human central nervous system. San Diego: Academic Press pp. 1001-1022 (1990).
38. Tork I, Mc Ritchie DA, Rikardo-Bell GC, Paxinos G. Autonomic regulatory centers in the medulla oblongata. In (Ed: Paxinos G). The human central nervous system. San Diego: Academic Press pp. 221-259 (1990).
39. Azmitia EC, Whitaker-Azmitia PM. Awakening the sleeping giant: anatomy and plasticity of the brain serotoninergic system. J Clin Psychiatry 52 (Suppl.): 4-16 (1991).
40. Huang XF, Paxinos G. Human intermediate reticular zone: A cytoand chemoarchitectonic study. J Comp Neurol 360: 571-88 (1995).
41. McRitchie DA, Hardman CD, Halliday GM. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans. J Comp Neurol 364: 121-50 (1996).
42. Rub U, Del Tredici, Schultz C, Thal DR, Braak E, Braak H. The autonomic higher order processing nuclei of the lower brain stem are among the early targets of the Alzheimer's disease-related cytoskeletal pathology. Acta Neuropathol 101: 555-64 (2001).
43. Rub U, Schultz C, Del Tredici K, Gierga K, Reifenberger G, de Vos RA, et al. Anatomically based guidelines for systematic investigation of the central somatosensory system and their application to a spinocerebellar ataxia type 2 (SCA2) patient. Neuropathol Appl Neurobiol 29: 418-33 (2003).
44. Hornung JP. The human raphe nuclei and the serotonergic system. J Chem Neuroanatomy 26: 331-43 (2003).
45. Rub U, Brunt ER, de Vos RA, Del Turco D, Del Tredici K, Gierga K, et al. Degeneration of the central vestibular system in spinocerebellar ataxia type 3 (SCA3) patients and its possible clinical significance. Neuropathol Appl Neurobiol 30: 402-14 (2004).
46. Rub U, Gierga K, Brunt ER, de Vos RA, Bauer M, Schols L, et al. Spinocerebellar ataxias types 2 and 3: degeneration of the precerebellar nuclei isolates the three phylogenetically defined regions of the cerebellum. J Neural Transm 112: 1523-45 (2005).
47. Leigh RJ, Zee DS. The Neurology of Eye Movements 4th ed. Oxford: Oxford University Press (2006).
48. Hoche F, Seidel K, Brunt ER, Auburger G, Schols L, Burk K, et al. Involvement of the auditory brainstem system in spinocerebellar ataxia type 2 (SCA2), type 3 (SCA3) and type 7 (SCA7). Neuropathol Appl Neurobiol 34: 479-91 (2008).
49. Rub U, Jen JC, Braak H, Deller T. Functional neuroanatomy of the human premotor oculomotor brainstem nuclei: insights from postmortem and advanced in vivo imaging studies. Exp Brain Res 187: 167-80 (2008).
50. Scinto LF, Wu CK, Firla KM, Daffner KR, Saroff D, Geula C. Focal pathology in the Edinger-Westphal nucleus explains pupillary hypersensitivity in Alzheimer's disease. Acta Neuropatholog 97: 557-64 (1999).
51. Rub U, Del Tredici K, Schultz C, Buttner-Ennever JA, Braak H. The premotor region essential for rapid vertical eye movements shows early involvement in Alzheimer's disease-related cytoskeletal pathology. Vision Res 41: 2149-56 (2001).
52. Rub U, Schultz C, Del Tredici K, Braak H. Early involvement of the tegmentopontine reticular nucleus during the evolution of Alzheimer's disease-related cytoskeletal pathology. Brain Res 908: 107-12 (2001).
53. Scinto LF, Frosch M, Wu CK, Daffner KR, Gedi N, Geula C. Selective cell loss in Edinger-Westphal in asymptomatic elders and Alzheimer's patients. Neurobiol Aging 22: 729-36 (2001).
54. Hertz L. Is Alzheimer's disease an anterograde degeneration, originating in the brainstem, and disrupting metabolic and functional interactions between neurons and glial cells? Brain Res Brain Res Rev 14: 335-53 (1989).
55. Simic G, Stanic G, Mladinov M, Jovanov-Milosevic N, Kostovic I, Hof PR. Does Alzheimer's disease begin in the brainstem? Neuropathol Appl Neurobiol 35: 532-54 (2009).
56. Ishino H, Otsuki S. Distribution of Alzheimer's neurofibrillary tangles in the basal ganglia and brain stem of progressive supranuclear palsy and Alzheimer's disease. Folia Psychiatr Neurol 29: 179-87 (1975).
57. Mann DM, Yates PO, Hawkes J. The pathology of the human locus ceruleus. Clin Neuropathol 2: 1-7 (1983).
58. Curcio CA, Kemper T. Nucleus raphe dorsalis in dementia of the Alzheimer type: neurofibrillary changes and neuronal packing density. J Neuropathol Exp Neurol 43: 359-68 (1984).
59. Hunter S. The rostral mesencephalon in Parkinson's disease and Alzheimer's disease. Acta Neuropathol 68: 53-8 (1985).
60. Tabaton M, Schenone A, Romagnoli P, Mancardi GL. A quantitative and ultrastructural study of substantia nigra and nucleus centralis superior in Alzheimer's disease. Acta Neuropathol 68: 218-23 (1985).
61. Yamamoto T, Hirano A. Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons. Ann Neurol 17: 573-7 (1985).
62. Bondareff W, Mountjoy CQ, Roth M, Rossor MN, Iversen LL, Reynolds et al. Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease. Alzheimer Dis Assoc Disord 1: 256-62 (1987).
63. Mann DM, Yates PO, Marcyniuk B. Dopaminergic neurotransmitter systems in Alzheimer's disease and in Down's syndrome at middle age. J Neurol Neurosurg Psychiatry 50: 341-4 (1987).
64. Jellinger K. The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry 51: 540-3 (1988).
65. Mufson EJ, Mash DC, Hersh LB. Neurofibrillary tangles in cholinergic pedunculopontine neurons in Alzheimer's disease. Ann Neurol 24: 623-9 (1988).
66. Zweig RM, Ross CA, Hedreen JC, Steele C, Cardillo JE, Whitehouse PJ, et al. The neuropathology of aminergic nuclei in Alzheimer's disease. Ann Neurol 24: 233-42 (1988).
67. Bondareff W, Mountjoy CQ, Roth M, Hauser DL. Neurofibrillary degeneration and neuronal loss in Alzheimer's disease. Neurobiol Aging 10: 709-15 (1989).
68. Gibb WR, Mountjoy CQ, Mann DM, Lees AJ. The substantia nigra and ventral tegmental area in Alzheimer's disease and Down's syndrome. J Neurol Neurosurg Psychiatry 52: 193-200 (1989).
69. Ohm TG, Braak H. Auditory brainstem nuclei in Alzheimer's disease. Neurosci Lett 96: 60-3 (1989).
70. Halliday GM, McCann HL, Pamphlett R, Brooks WS, Creasey H, McCusker E, et al. Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation. Acta Neuropathol 84: 638-50 (1992).
71. Uchihara T, Kondo H, Kosaka K, Tsukagoshi H. Selective loss of nigral neurons in Alzheimer's disease: a morphometric study. Acta Neuropathol 83: 271-6 (1992).
72. Giess R, Schlote W. Localisation and association of pathomorphological changes at the brainstem in Alzheimer's disease. Mech Ageing Dev 84: 209-26 (1995).
73. Parvizi J, Van Hoesen GW, Damasio A. Selective pathological changes of the periaqueductal gray matter in Alzheimer's disease. Ann Neurol 48: 344-53 (2000).
74. Parvizi J, Van Hoesen GW, Damasio A. The selective vulnerability of brainstem nuclei to Alzheimer's disease. Ann Neurol 49: 53-66 (2001).
75. Hendricksen M, Thomas AJ, Ferrier IN, Ince P, O'Brien JT. Neuropathological study of the dorsal raphe nuclei in late-life depression and Alzheimer's disease with and without depression. Am J Psychiatry 161: 1096-102 (2004).
76. Burns JM, Galvin JE, Roe CM, Morris JC, McKeel DW. The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs. Neurology 64: 1397-1403 (2005).
77. Braak H, Thal DR, Ghebremedhin E, Del Tredici. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70: 960-9 (2011).
78. Amaral DG, Cowan WM. Subcortical afferents to the hippocampal formation in the monkey. J Comp Neurol 189: 573-91 (1980).
79. Breen LA, Burde RM, Loewy AD. Brainstem connections to the Edinger-Westphal nucleus of the cat: a retrograde tracer study. Brain Res 261: 303-6 (1983).
80. Matsuyama K, Ohta Y, Mori S. Ascending and descending projections of the nucleus reticularis gigantocellularis in the cat demonstrated by the anterograde neural tracer, Phaseolus vulgaris leucoagglutinin (PHA-L). Brain Res 460: 124-41 (1988).
81. Torigoe Y, Blanks RH, Precht W. Anatomical studies on the nucleus reticularis tegmenti pontis in the pigmented rat. I. Cytoarchitecture, topography, and cerebral cortical afferents. J Comp Neurol 243: 71-87 (1986).
82. Giolli RA, Gregory KM, Suzuki DA, Blanks RH, Lui F, Betelak KF. Cortical and subcortical afferents to the nucleus reticularis tegmenti pontis and basal pontine nuclei in the macaque monkey. Vis Neurosci 18: 725-40 (2001).
83. Jurgens U. Neural pathways underlying vocal control. Neurosci Biobehav Rev 26: 235-258 (2002)
84. Kozicz T, Bittencourt JC, May PJ, Reiner A, Gamlin PD, Palkovits M, et al. The Edinger-Westphal nucleus: a historical, structural, and functional perspective on a dichotomous terminology. J Comp Neurol 519: 1413-34 (2011).
85. Braak H, Rub U, Sandmann-Keil D, Gai WP, de Vos RA, Jansen Steur EN. Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system. Acta Neuropathol 99: 489-95 (2000).